
Putting MSM on the radar
A three-day conference to be held in Cape Town from today will focus on men who have sex with men (MSM) as a key target group to consider in developing policy and interventions for HIV prevention and treatment.

A three-day conference to be held in Cape Town from today will focus on men who have sex with men (MSM) as a key target group to consider in developing policy and interventions for HIV prevention and treatment.
The 2011 influenza season is upon us and people, more particularly high risk persons, are strongly encouraged to get vaccinated to avoid major complications such as pneumonia.

In the last 20 years there has been a steady increase of pneumonia cases in adults, mostly in people living with HIV. A significant proportion of those infected die.

CAPE TOWN '€“ A multi-million rand AngloGold Ashanti investment in a malaria control programme in Ghana has led to massive reductions in productivity losses, school absenteeism, infant mortality and treatment costs, a report released at the World Economic Forum has shown.

The University of Limpopo Medunsa campus this week launched a clinical scientific trial to test a vaccine developed in Italy to investigate whether it can slow HIV progression in people already living with the HI-virus.
Against the back-drop of diminishing donor support for national AIDS programmes in Africa and the rest of the developing world, the question on many minds is: What role should individual states play to ensure that their citizens continue to receive critical care?
A controversial US project that pays drug users and alcoholics to undergo sterilisation or long-term contraception, is setting its sights on women living with HIV in South Africa.

Civil society organisations want to see government taking a firmer stand to stop antiretroviral drugs (ARVs) from being smuggled onto the black market.

With about 500 000 South Africans estimated to be newly-infected with tuberculosis annually, South Africa is a TB high-risk area for children. Yet, no data exists on the incidence of paediatric TB and very few children are diagnosed.
Dis-Chem this week responded to criticism after their involvement in the tour to South Africa of vitamin salesman and author Patrick Holford.

Health campaigners in east and southern Africa want the United Nations to develop a policy framework to ensure that countries honour and implement the right to health care.

Tuberculosis is the leading cause of natural death in South Africa and over 10% of all new TB cases are drug resistant. One of the most important measures for controlling the spread of the bacteria is quick diagnosis and treatment. Revolutionary new testing technology may make this possible.
The Treatment Action Campaign (TAC) says Tuberculosis (TB) is underfunded and progress action against the epidemic is slow. TB has been one of the most important causes of premature death in South Africa, made worse by the HIV pandemic.

In a profession often marred by disillusionment, poor resources and negative publicity, some nurses still manage to uphold their ethics and even risk their lives by working in highly infectious environments.
The Southern African HIV Clinicians Society and the Treatment Action Campaign have demanded that Dis-Chem explain its decision to host vitamin salesman Patrick Holford.